Global Custom Market Research Reports Provider Company

phone

Protagonist Therapeutics Inc (PTGX) - Financial and Strategic SWOT Analysis Review

  • Published Date: 31 Jul 2018
  • Number of Pages: 48
  • Category: SWOT Analysis
  • Country: United States of America
Protagonist Therapeutics Inc (PTGX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Protagonist Therapeutics Inc (Protagonist) is a clinical-stage biopharmaceutical company that discovers and develops orally stable peptides as targeted therapies. The company through its proprietary technology platform develops structurally novel oral or injectable peptides for protein-protein interaction targets. Protagonists peptides specifically target biological pathways that are also targeted by currently marketed injectable antibody drugs. The companys product candidates are intended for the treatment of inflammatory bowel disease and other gastrointestinal diseases and disorders. It operates in the US and Australia. Protagonist is headquartered in Milpitas, California, the US.

Protagonist Therapeutics Inc Key Recent Developments

May 24,2018: Protagonist Therapeutics Names Samuel Saks, M.D., as Chief Development Officer
May 16,2018: Protagonist Therapeutics Appoints Bryan Giraudo to Board of Directors
May 09,2018: Protagonist Therapeutics Reports First Quarter 2018 Financial Results
Mar 07,2018: Protagonist Therapeutics Reports Fourth Quarter and Year-End 2017 Financial Results
Dec 14,2017: Protagonist Therapeutics Appoints Sarah Noonberg, M.D., Ph.D. to the Board of Directors

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company
Publisher Name : GlobalData
Section 1 - About the Company 6
Protagonist Therapeutics Inc - Key Facts 6
Protagonist Therapeutics Inc - Key Employees 7
Protagonist Therapeutics Inc - Key Employee Biographies 8
Protagonist Therapeutics Inc - Major Products and Services 9
Protagonist Therapeutics Inc - History 10
Protagonist Therapeutics Inc - Company Statement 11
Protagonist Therapeutics Inc - Locations And Subsidiaries 13
Head Office 13
Other Locations & Subsidiaries 13
Section 2 Company Analysis 14
Company Overview 14
Protagonist Therapeutics Inc - Business Description 15
Protagonist Therapeutics Inc - SWOT Analysis 16
SWOT Analysis - Overview 16
Protagonist Therapeutics Inc - Strengths 16
Protagonist Therapeutics Inc - Weaknesses 17
Protagonist Therapeutics Inc - Opportunities 18
Protagonist Therapeutics Inc - Threats 19
Protagonist Therapeutics Inc - Key Competitors 20
Section 3 Company Financial Ratios 21
Financial Ratios - Capital Market Ratios 21
Financial Ratios - Annual Ratios 22
Performance Chart 24
Financial Performance 24
Financial Ratios - Interim Ratios 25
Financial Ratios - Ratio Charts 26
Section 4 Companys Lifesciences Financial Deals and Alliances 27
Protagonist Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27
Protagonist Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 28
Protagonist Therapeutics Inc, Recent Deals Summary 29
Section 5 Companys Recent Developments 30
May 24, 2018: Protagonist Therapeutics Names Samuel Saks, M.D., as Chief Development Officer 30
May 16, 2018: Protagonist Therapeutics Appoints Bryan Giraudo to Board of Directors 31
May 09, 2018: Protagonist Therapeutics Reports First Quarter 2018 Financial Results 32
Mar 07, 2018: Protagonist Therapeutics Reports Fourth Quarter and Year-End 2017 Financial Results 34
Dec 14, 2017: Protagonist Therapeutics Appoints Sarah Noonberg, M.D., Ph.D. to the Board of Directors 36
Nov 06, 2017: Protagonist Therapeutics Reports Third Quarter 2017 Financial Results and Provides Corporate Update 37
Aug 08, 2017: Protagonist Therapeutics Reports Second Quarter 2017 Financial Results and Business Highlights 39
Jun 08, 2017: Protagonist Therapeutics Appoints Five Prime Therapeutics CEO, Lewis T. "Rusty" Williams, to its Board of Directors 41
May 10, 2017: Protagonist Therapeutics Reports First Quarter 2017 Financial Results 42
Mar 07, 2017: Protagonist Therapeutics Reports Fourth Quarter and Year-End 2016 Financial Results 43
Section 6 Appendix 44
Methodology 44
Ratio Definitions 44
About GlobalData 48
Contact Us 48
Disclaimer 48

List Of Tables


Protagonist Therapeutics Inc, Key Facts 6
Protagonist Therapeutics Inc, Key Employees 7
Protagonist Therapeutics Inc, Key Employee Biographies 8
Protagonist Therapeutics Inc, Major Products and Services 9
Protagonist Therapeutics Inc, History 10
Protagonist Therapeutics Inc, Subsidiaries 13
Protagonist Therapeutics Inc, Key Competitors 20
Protagonist Therapeutics Inc, Ratios based on current share price 21
Protagonist Therapeutics Inc, Annual Ratios 22
Protagonist Therapeutics Inc, Annual Ratios (Cont...1) 23
Protagonist Therapeutics Inc, Interim Ratios 25
Protagonist Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27
Protagonist Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 28
Protagonist Therapeutics Inc, Recent Deals Summary 29
Currency Codes 44
Capital Market Ratios 44
Equity Ratios 45
Profitability Ratios 45
Cost Ratios 46
Liquidity Ratios 46
Leverage Ratios 47
Efficiency Ratios 47

List Of Figures


Protagonist Therapeutics Inc, Performance Chart (2014 - 2017) 24
Protagonist Therapeutics Inc, Ratio Charts 26
Protagonist Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 27
Protagonist Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 28

TOP Ships Inc (TOPS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by

View Report

Payton Planar Magnetics Ltd (PAY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled

View Report

Allied Motion Technologies, Inc. (AMOT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports